230 related articles for article (PubMed ID: 34438988)
1. In Vitro Antimicrobial Susceptibilities of
Martínez-Martínez S; Rodríguez-Ferri EF; Rodríguez-Lázaro D; Hernández M; Gómez-Campillo JI; Martínez-Nistal MDC; Fernández-Natal MI; García-Iglesias MJ; Mínguez-González O; Gutiérrez-Martín CB
Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34438988
[TBL] [Abstract][Full Text] [Related]
2. Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species.
Georgi E; Schacht E; Scholz HC; Splettstoesser WD
J Antimicrob Chemother; 2012 Oct; 67(10):2429-33. PubMed ID: 22763567
[TBL] [Abstract][Full Text] [Related]
3. [In Vitro Activity of Tigecycline Against Francisella tularensis Subsp. holarctica in Comparison with Doxycycline, Ciprofloxacin and Aminoglycosides].
Ulu Kılıç A; Kılıç S; Celebi B; Sencan I
Mikrobiyol Bul; 2013 Jan; 47(1):189-91. PubMed ID: 23390918
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of field isolates of Francisella tularensis subsp. holarctica recovered in Spain to several antimicrobial agents.
García del Blanco N; Gutiérrez Martín CB; de la Puente Redondo VA; Rodríguez Ferri EF
Res Vet Sci; 2004 Jun; 76(3):195-8. PubMed ID: 15046952
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of isolates of Francisella tularensis from Turkey.
Kiliç S; Celebi B; Acar B; Ataş M
Scand J Infect Dis; 2013 May; 45(5):337-41. PubMed ID: 23249114
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
Caspar Y; Hennebique A; Maurin M
J Antimicrob Chemother; 2018 Mar; 73(3):687-691. PubMed ID: 29253157
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.
Tomaso H; Al Dahouk S; Hofer E; Splettstoesser WD; Treu TM; Dierich MP; Neubauer H
Int J Antimicrob Agents; 2005 Oct; 26(4):279-84. PubMed ID: 16143497
[TBL] [Abstract][Full Text] [Related]
8. Genetic Diversity and Spatial Segregation of
Appelt S; Köppen K; Radonić A; Drechsel O; Jacob D; Grunow R; Heuner K
Front Cell Infect Microbiol; 2019; 9():376. PubMed ID: 31781515
[No Abstract] [Full Text] [Related]
9. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
Tomaso H; Hotzel H; Otto P; Myrtennäs K; Forsman M
J Antimicrob Chemother; 2017 Sep; 72(9):2539-2543. PubMed ID: 28605439
[TBL] [Abstract][Full Text] [Related]
10. Differential Substrate Usage and Metabolic Fluxes in
Chen F; Rydzewski K; Kutzner E; Häuslein I; Schunder E; Wang X; Meighen-Berger K; Grunow R; Eisenreich W; Heuner K
Front Cell Infect Microbiol; 2017; 7():275. PubMed ID: 28680859
[No Abstract] [Full Text] [Related]
11. Environmental Monitoring and Surveillance of Rodents and Vectors for Francisella tularensis Following Outbreaks of Human Tularemia in Georgia.
Elashvili E; Kracalik I; Burjanadze I; Datukishvili S; Chanturia G; Tsertsvadze N; Beridze L; Shavishvili M; Dzneladze A; Grdzelidze M; Imnadze P; Pearson A; Blackburn JK
Vector Borne Zoonotic Dis; 2015 Oct; 15(10):633-6. PubMed ID: 26394283
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibilities of Francisella tularensis subsp. holarctica strains isolated from humans in the Central Anatolia region of Turkey.
Yesilyurt M; Kiliç S; Celebi B; Celik M; Gül S; Erdogan F; Ozel G
J Antimicrob Chemother; 2011 Nov; 66(11):2588-92. PubMed ID: 21856791
[TBL] [Abstract][Full Text] [Related]
13. Revisiting
Busch A; Thomas P; Zuchantke E; Brendebach H; Neubert K; Gruetzke J; Al Dahouk S; Peters M; Hotzel H; Neubauer H; Tomaso H
Front Microbiol; 2018; 9():344. PubMed ID: 29593661
[No Abstract] [Full Text] [Related]
14. Genotyping of Francisella tularensis strains by pulsed-field gel electrophoresis, amplified fragment length polymorphism fingerprinting, and 16S rRNA gene sequencing.
García Del Blanco N; Dobson ME; Vela AI; De La Puente VA; Gutiérrez CB; Hadfield TL; Kuhnert P; Frey J; Domínguez L; Rodríguez Ferri EF
J Clin Microbiol; 2002 Aug; 40(8):2964-72. PubMed ID: 12149360
[TBL] [Abstract][Full Text] [Related]
15. Vole outbreaks may induce a tularemia disease pit that prevents Iberian hare population recovery in NW Spain.
Rouco C; Luque-Larena JJ; Vidal D; Mougeot F
Sci Rep; 2023 Mar; 13(1):3898. PubMed ID: 36890167
[TBL] [Abstract][Full Text] [Related]
16. [Determination of the Subspecies of Francisella tularensis Isolated in Turkey by Molecular Methods].
Çelebi B; Bakkaloğlu Z; Ünaldı Ö; Karagöz A; Kılıç S; Durmaz R
Mikrobiyol Bul; 2020 Jan; 54(1):1-10. PubMed ID: 32050874
[TBL] [Abstract][Full Text] [Related]
17. Presence of
Brunet CD; Hennebique A; Peyroux J; Pelloux I; Caspar Y; Maurin M
Microorganisms; 2021 Jun; 9(7):. PubMed ID: 34203503
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Francisella tularensis subsp. holarctica strains from Hungary, Central Europe.
Kreizinger Z; Makrai L; Helyes G; Magyar T; Erdélyi K; Gyuranecz M
J Antimicrob Chemother; 2013 Feb; 68(2):370-3. PubMed ID: 23065699
[TBL] [Abstract][Full Text] [Related]
19.
Caspar Y; Maurin M
Front Cell Infect Microbiol; 2017; 7():122. PubMed ID: 28443249
[TBL] [Abstract][Full Text] [Related]
20. Hare-to-human transmission of Francisella tularensis subsp. holarctica, Germany.
Otto P; Kohlmann R; Müller W; Julich S; Geis G; Gatermann SG; Peters M; Wolf PJ; Karlsson E; Forsman M; Myrtennäs K; Tomaso H
Emerg Infect Dis; 2015 Jan; 21(1):153-5. PubMed ID: 25531286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
